CIAP1 E3 ligase inhibitor D19-14

CIAP1 E3 ligase inhibitor D19-14 (cIAP1 inhibitor D19-14) is an improved analog of D19, demonstrates significantly increased ability to inhibit cIAP1 autoubiquitination and reduce protein levels of c-MYC in vitro.

Product Specifications

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

385.456

Molecular Formula

C18H15N3O3S2

Notes

Research use only, not for human use.

Receptor

E3 Ubiquitin Ligase

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS6245106-01 0.1 mL

CREB, phosphorylated (Ser133) (cAMP Response Element Binding Protein) (MaxLight 405)

Ask

View Details

MBS6245106-02 5x 0.1 mL

CREB, phosphorylated (Ser133) (cAMP Response Element Binding Protein) (MaxLight 405)

Ask

View Details

MBS4380372-01 0.02 mg (With BSA & Azide at 0.2mg/mL)

CD79b (B-Cell Marker)

Ask

View Details

MBS4380372-02 0.1 mg (With BSA & Azide at 0.2mg/mL)

CD79b (B-Cell Marker)

Ask

View Details

MBS4380372-03 0.1 mg (Without BSA & Azide at 1mg/mL)

CD79b (B-Cell Marker)

Ask

View Details

MBS4380372-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)

CD79b (B-Cell Marker)

Ask

View Details